Fig. 1. Proteins in particles of BRV purified from CsCI density gradients after equilibrium ultracentrifugation. Lanes 2 and 5, lower band of 1.38 g/ml density; lanes 3 and 6, middle band of 1.36 g/ml density; lanes 4 and 7, upper band of 1.30 g/ml density; lane 1, BRV-infected cell proteins. Labelling of preparations in lanes 1 to 4 was with pS]methionine, in lanes 5 to 7 with [3H]myristic acid. Separation was on a 15% polyacrylamide gel using Laemmli's (1970) buffer system. The gel was then fixed, treated with EnaHance and autoradiographed. The viral proteins (VP1 to VP 10) are indicated on the left; the nomenclature of McCrae & McCorquodale (1982) was used. VPS* is a cleavage product of VP4 (Estes et al., 1981; Liu et al., 1988) . acid (sp. act. 48 Ci/mmol; Amersham) and [9,10(n)-3H]palmitic acid (sp. act. 54 Ci/mmol; Amersham) were dried under an nitrogen stream and redissolved in 10 ml of culture medium; virus was grown in the presence of 1 mCi of myristic acid or palmitic acid per bottle which was added after the adsorption step. In parallel, cultured virus was labelled with 500 ~tCi of [35S]methionine (sp. act. 1415 Ci/mmol; Amersham) per bottle as described (Hundley et al., 1985) . When full c.p.e, was reached, cultures were frozen and thawed twice and the virus was semi-purified by differential ultracentrifugation through a sucrose cushion as described (Follett & Desselberger, 1983) . Virus was then extracted with Freon and banded in CsCI gradients (McCrae, 1985) . Bands of densities 1-38, 1.36 and 1.30 g/ml (representing RNA-containing single-shelled, RNA-containing double-shelled and empty virus particles, respectively) were collected, diluted with phosphate-buffered saline, and the virus was re-pelleted; the pellets were resuspended in 10 to 20 ~1 of water. Aliquots were mixed with different electrophoresis loading buffers and the proteins separated on 15% polyacrylamide gels using Laemmli's (1970) buffer system. Reproducible labelling with myristic acid was obtained, and a typical result is shown in acid :acetonitrile (1:1) (Chow et al., 1987) using [3H]myristic acid and [3H]palmitic acid as markers. Alternatively, reverse-phase HPLC using a Micro-Bondapack C18 column (Waters Associates) was carried out using an acetonitrile :trifluoroacetic acid (TFA) gradient. The column was equilibrated with 0-1 ~ TFA in water :0-05~ TFA in acetonitrile (95:5) and a linear gradient was applied to reverse the buffer components to 5 : 95 within 8 min. The column eluents were continuously measured for 3H content using a Ramona Raytest flow-through scintillation counter. Data were stored on an IBM PC running under the Ramona RadioChromatography System program version 10.1 (Raytest Instruments) (Darling et al., 1987) . It was found that the liberated fatty acid always comigrated with the myristic acid marker (Fig.  3) ; palmitic acid was thus metabolized to myristic acid before esterification into viral proteins. Identical results were obtained from the HPLC data (not shown). In picornavirus-infected cells similar observations have been made (Chow et al., 1987) . The rotavirus proteins VP2 and VP6 were found to contain myristic acid in an amide linkage. This could have been to the e-NH2 group of a lysine residue or the N-terminal amino acid of the protein. In most cases of myristylation of viral proteins this has been in an N-terminal glycine residue (Table 1 of Chow et al., 1987;  Table 2 of Paul et al., 1987) . The sequence of the gene coding for VP6 of BRV (RF strain), determined by Cohen et al. (1984) , is highly conserved in comparison with the sequence of the VP6 gene Of SA 11 virus . There is no Nterminal glycine in the VP6 sequence but lysines in positions 9 and 11 ; the first glycine is found in position 21 from the N terminus and is followed by a serine in position 25. This corresponds to a consensus sequence for myristylation (GIy-X-X-X-Ser/Thr) proposed by Chow et al. (1987) and would make it a good candidate for myristylation, provided that the first 20 amino acids of VP6 were post-translationally cleaved off like a leader peptide. It remains to be seen whether this is the case. Proteolytic removal of a leader peptide to produce an N-terminal glycine for myristylation is necessary in cardio-and aphthoviruses (Chow~et al., 1987) and there is some speculation that this may also be the case for the VP4 equivalent of hepatitis A virus (Cohen et al., 1987; Chow et al., 1987) .
The finding that VP2 and VP6 of rotaviruses are myristylated raises the question of the functional significance of this modification. VP2 is the major core protein and VP6 the major inner capsid protein of rotaviruses (McCrae & McCorquodale, 1982; Arias et al., 1982) . Both may act as scaffolding proteins for the formation of virus particles; this function was proposed for the myristylated VP2s of SV40 and polyoma viruses (Streuli & Griffin, 1987) , 1987) ; the gag precursors were synthesized, but not myristylated and not cleaved from the mature protein, and immature particles accumulated in the cytoplasm but were not released. This result indicated a function in intracellular transport to the plasma membrane for myristylated proteins of the MPMV. As rotaviruses are not shed by budding, this function for myristylation is less likely than a scaffolding role. It can be expected that analysis of mutants and progress in the manipulation and expression of rotavirus genes will further elucidate the function of myristylation of rotavirus proteins.
